The Cybersecurity and Infrastructure Security Agency and Food and Drug Administration Jan. 30 released notices warning of ...

The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

Pharma, biopharma, and medical device makers should watch out for these perennial problems, which include inadequate ...

Vulnerabilities in certain Contec and Epsimed patient monitors can allow people to gain access and potentially manipulate the ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.

The approval Journey Medical received from FDA for Emrosi makes DERM an exciting stock. Click here to read more.

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...

Among the wave of guidance documents issued by the U.S. Food and Drug Administration (“FDA” or the “Agency”) in the first week of 2025 were ...

TAVIPILOT Soft is said to be a ‘world-first’ provision for real-time surgical guidance during TAVI and TAVR procedures.